 Anixa Biosciences, Inc. NASDAQ: ANIX, a biotechnology company focused on harnessing the bodys immune system in the fight against cancer, today announced that data related to Anixas recently launched CchekTM Prostate Cancer Confirmation test CchekTM PCC will be presented at the AI and Big Data in Cancer: From Innovation to Impact conference. CchekTM is Anixas artificial intelligence AI driven cancer detection technology. 